These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8093631)

  • 1. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.
    Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB
    Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
    Morgan D; Cook CD; Smith MA; Picker MJ
    Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dezocine, morphine and nalbuphine on electropain threshold, temperature pain threshold and cardiac function in rats with myocardial ischemia.
    Dong Y; Liang Z; Xu Z; Hao W; Wang D; Huo S; Zhao H
    Ann Palliat Med; 2020 Jul; 9(4):1556-1563. PubMed ID: 32762221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial intravenous doses of dezocine, morphine, and nalbuphine in the management of postoperative pain for outpatients.
    Cohen RI; Edwards WT; Kezer EA; Ferrari DA; Liland AE; Smith ER
    Anesth Analg; 1993 Sep; 77(3):533-9. PubMed ID: 8368552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dezocine Alleviates Morphine-Induced Dependence in Rats.
    Wu FX; Babazada H; Gao H; Huang XP; Xi CH; Chen CH; Xi J; Yu WF; Liu R
    Anesth Analg; 2019 Jun; 128(6):1328-1335. PubMed ID: 31094808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular targets of dezocine and their clinical implications.
    Liu R; Huang XP; Yeliseev A; Xi J; Roth BL
    Anesthesiology; 2014 Mar; 120(3):714-23. PubMed ID: 24263237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profiles of opioid ligands at kappa opioid receptors.
    Gharagozlou P; Hashemi E; DeLorey TM; Clark JD; Lameh J
    BMC Pharmacol; 2006 Jan; 6():3. PubMed ID: 16433932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain.
    Wu LX; Dong YP; Zhu QM; Zhang B; Ai BL; Yan T; Zhang GH; Sun L
    BMC Cancer; 2021 Oct; 21(1):1128. PubMed ID: 34670518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.
    Bian X; Zhou R; Yang Y; Li P; Hang Y; Hu Y; Yang L; Wen D
    Int J Med Sci; 2015; 12(11):848-52. PubMed ID: 26640403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid binding sites in human serum albumin.
    Zhou R; Perez-Aguilar JM; Meng Q; Saven JG; Liu R
    Anesth Analg; 2012 Jan; 114(1):122-8. PubMed ID: 22025496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of intravenous doses of dezocine, butorphanol, and placebo for relief of postoperative pain.
    Galloway FM; Varma S
    Anesth Analg; 1986 Mar; 65(3):283-7. PubMed ID: 2869723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.